Skip to main content
Caplight Logo









Cortex Discovery

Cortex Discovery

Private
GermanyHealthcare & Life Scienceshttps://cortexdiscovery.com/

Company Overview

Cortex Discovery operates in Healthcare & Life Sciences and is based in Germany. It was founded in 2021.

Cortex Discovery is a biotechnology company that provides AI-driven drug discovery services, including virtual high-throughput screening and ADMET profiling, to accelerate preclinical drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Foundation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cortex Discovery Comparables

Compare Cortex Discovery with similar companies based on industry and business-model similarity.

Cortex Discovery comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anyo Labs
89%
Genesis Molecular AI
79%
Terray Therapeutics
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cortex Discovery Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Cortex Discovery. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ivan De Weber

Co-Founder and CEO

Founding Team

For institutional investors. Book with your work email.

Cortex Discovery Filings

Explore SEC and related filing metadata, where available.

Cortex Discovery filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cortex Discovery's valuation, stock price, and market status.

Is Cortex Discovery a public or private company?

Cortex Discovery is a private company.

What is the current stock price of Cortex Discovery?

Cortex Discovery is a private company, so its shares have no public market price. Caplight tracks Cortex Discovery's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cortex Discovery worth (valuation)?

Valuation information for Cortex Discovery is not publicly available.

Can I buy Cortex Discovery stock?

Cortex Discovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cortex Discovery's last funding round?

Funding round information for Cortex Discovery is not publicly available.

Who are the main investors in Cortex Discovery?

Investor information for Cortex Discovery is not publicly disclosed.

Will Cortex Discovery IPO soon?

No public IPO plans have been announced for Cortex Discovery.

How can I track Cortex Discovery secondary market activity?

Caplight tracks bids, offers, and trades in Cortex Discovery's shares on secondary markets.

Firmographic Details

HeadquartersGermany
Employee Range5
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?